ID
25564
Description
Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00497133
Link
https://clinicaltrials.gov/show/NCT00497133
Keywords
Versions (1)
- 9/5/17 9/5/17 -
Uploaded on
September 5, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes Mellitus NCT00497133
Eligibility Type 2 Diabetes Mellitus NCT00497133
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Liver disease | Alanine aminotransferase increased
Data type
boolean
Alias
- UMLS CUI [1]
- C0023895
- UMLS CUI [2]
- C0151905
Description
Diabetic Nephropathy | Creatinine measurement, serum | Albuminuria
Data type
boolean
Alias
- UMLS CUI [1]
- C0011881
- UMLS CUI [2]
- C0201976
- UMLS CUI [3]
- C0001925
Description
Diabetic Neuropathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0011882
Description
Proliferative diabetic retinopathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0154830
Description
Therapeutic procedure Discontinue Unsuccessful
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C1444662
- UMLS CUI [1,3]
- C1272705
Description
Insulin regime | glitazone
Data type
boolean
Alias
- UMLS CUI [1]
- C0557978
- UMLS CUI [2]
- C1257987
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00497133
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0011860 (UMLS CUI [3])
C0151905 (UMLS CUI [2])
C0201976 (UMLS CUI [2])
C0001925 (UMLS CUI [3])
C1444662 (UMLS CUI [1,2])
C1272705 (UMLS CUI [1,3])
C1257987 (UMLS CUI [2])